Skip to content

S. Aureus Colonization in Atopic Dermatitis

Staphylococcus Aureus Colonization in Atopic Dermatitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02091037
Enrollment
114
Registered
2014-03-19
Start date
2011-12-31
Completion date
2017-01-11
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Keywords

Atopic dermatitis, Bacterial colonization

Brief summary

The purpose of this study is to characterize the bacterial strains that colonize children with atopic dermatitis. The investigators hypothesize that rectal cultures will be more sensitive than anterior nares cultures for detecting S. aureus colonization, and that strains of S. aureus colonizing patients with atopic dermatitis will be resistant to commonly used topical antibiotic ointments.

Detailed description

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by pruritis and eczematous lesions with a worldwide prevalence of 15-20%. The burden of disease is highest in the most developed nations and predominantly affects children, with 50% of cases arising in the first year of life, and most others arising in the first 5 years. There is a well-known increased susceptibility to skin infection with S. aureus in patients with AD, and such infections are associated with clinical deterioration. While it is routine to evaluate for S. aureus colonization in the anterior nares, there is recent evidence suggesting that rectal colonization may be more significant. The significance of colonization site has not been evaluated in the AD population. Additionally, while topical antibiotics are a mainstay of treatment in AD, there is no routine data on the resistance to these agents. Our aim is to characterize the S. aureus colonization patterns in children with AD, including site of colonization and antibiotic resistance. We will analyze routinely-collected skin culture specimens from children with AD seen at our center and determine antibiotic susceptibility profiles. The significance of colonization site will be analyzed.

Interventions

None listed

Sponsors

Society for Pediatric Dermatology
CollaboratorOTHER
Columbia University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* subjects with a diagnosis of atopic dermatitis seen by the Columbia University Medical Center department of dermatology * subjects ages 0 to 18 years

Exclusion criteria

* those patients in which a definitive diagnosis of AD cannot be made * subjects over the age of 18 years old * subjects with evidence of acute systemic illness * subjects currently taking systemic antibiotics * subjects with viral or fungal skin infection * any individual who declines participation

Design outcomes

Primary

MeasureTime frame
Difference in rectal and nasal S. aureus colonization rates in a population of children with atopic dermatitisUp to 3 years

Secondary

MeasureTime frame
Rates of resistance to commonly used topical antibiotic ointments in strains of S. aureus that colonize a population of children with atopic dermatitisUp to 20 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026